Efficacy of intravenous parecoxib in preventing post-endoscopic retrograde cholangiopancreatography pancreatitis: a randomized controlled trial - Quiz - MDSpire

Efficacy of intravenous parecoxib in preventing post-endoscopic retrograde cholangiopancreatography pancreatitis: a randomized controlled trial

  • By

  • Thanaput Kunlayawutipong

  • Tummarong Charoenrit

  • Tanawat Jongraksak

  • Thanawin Wong

  • Nisa Netinatsunton

  • Siriboon Attasaranya

  • Thanapon Yaowmaneerat

  • Jaksin Sottisuporn

  • Suraphon Assawasuwannakit

  • Siwanon Nawalerspanya

  • Surawitch Sawathanon

  • Pimsiri Sripongpun

  • Tanawat Pattarapuntakul

  • February 23, 2026

  • 0 min

Share

Original Source(s)

Efficacy of intravenous parecoxib in preventing post-endoscopic retrograde cholangiopancreatography pancreatitis: a randomized controlled trial

  • by Thanaput Kunlayawutipong, Tummarong Charoenrit, Tanawat Jongraksak, Thanawin Wong, Nisa Netinatsunton, Siriboon Attasaranya, Thanapon Yaowmaneerat, Jaksin Sottisuporn, Suraphon Assawasuwannakit, Siwanon Nawalerspanya, Surawitch Sawathanon, Pimsiri Sripongpun, Tanawat Pattarapuntakul

  • February 23, 2026

Related Content

Editorial: Enhanced recovery after vascular surgery: state of the art and future perspectives

Botulinum Toxin Evaluated in Digital Ischemia

Individual-level meta-analysis examines response, dosing, and safety across ischemic etiologies

Lumbar Fusion: Two Decades of Change

Investigators find rising use of complex lumbar fusion procedures and increasing hospital costs in the US.